The molecular origin and taxonomy of mucinous ovarian carcinomaDane Cheasley, Goli Samimi, Matthew J. Wakefield et al.|Nature Communications|2019Cited by 191
Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and <i>TP53</i> -Mutant Tumors and Identifies <i>NRAS</i> as an Oncogenic DriverCatherine Emmanuel, Anna DeFazio, Yoke-Eng Chiew et al.|Clinical Cancer Research|2014Cited by 119
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancerDale W. Garsed, David D.L. Bowtell, Ahwan Pandey et al.|Nature Genetics|2022Cited by 115
Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and OutcomesKelly L. Bolton, Elli Papaemmanuil, Denise Chen et al.|Clinical Cancer Research|2022Cited by 103
Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian CancerDale W. Garsed, Kathryn Alsop, Sián Fereday et al.|Clinical Cancer Research|2017Cited by 95